New Edge Advisors, LLC Amgen Inc Transaction History

New Edge Advisors, LLC

$15 Billion
Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 65,313 shares of AMGN stock, worth $18.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

65,313

Previous 63,809 2.36%

Holding current value

$18.8 Million

Previous $19.9 Million 5.55%

% of portfolio

0.14%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $465,307 - $507,419	1,504 Added 2.36%	65,313 $21 Million
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $3.56 Million - $4.32 Million	13,542 Added 26.94%	63,809 $19.9 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $52,429 - $63,289	-195 Reduced 0.39%	50,267 $14.3 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.78 Million - $2.01 Million	6,980 Added 16.05%	50,462 $14.5 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $804,850 - $999,244	-3,681 Reduced 7.8%	43,482 $11.7 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $833,081 - $985,102	3,888 Added 8.98%	47,163 $10.5 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $464,450 - $566,086	-2,057 Reduced 4.54%	43,275 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.16 Million - $4.01 Million	13,776 Added 43.66%	45,332 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.1 Million - $1.24 Million	4,893 Added 18.35%	31,556 $7.11 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $319,071 - $355,071	-1,383 Reduced 4.93%	26,663 $6.49 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $85,296 - $94,359	-389 Reduced 1.37%	28,046 $6.78 Million
Q4 2021 Feb 17, 2022	BUY	$198.88 - $227.6 $3.16 Million - $3.61 Million	15,865 Added 126.21%	28,435 $6.4 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $375,505 - $439,950	-1,769 Reduced 12.34%	12,570 $2.67 Million
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $779,923 - $865,268	-3,339 Reduced 18.89%	14,339 $3.5 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $816,406 - $951,389	-3,679 Reduced 17.23%	17,678 $4.4 Million
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $2.55 Million - $3.03 Million	-11,770 Reduced 35.53%	21,357 $4.91 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $2.11 Million - $2.35 Million	8,998 Added 37.29%	33,127 $8.42 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $279,505 - $342,991	1,413 Added 6.22%	24,129 $5.69 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $994,665 - $1.32 Million	5,458 Added 31.63%	22,716 $4.61 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $1.09 Million - $1.4 Million	5,740 Added 49.84%	17,258 $4.16 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $353,791 - $423,915	2,032 Added 21.42%	11,518 $2.24 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $9.15 Million - $10.7 Million	-54,868 Reduced 85.26%	9,486 $1.75 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $2.53 Million - $2.85 Million	13,978 Added 27.75%	64,354 $573,000
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $8.02 Million - $9.36 Million	44,946 Added 827.73%	50,376 $9.81 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $47,063 - $53,058	-254 Reduced 4.47%	5,430 $1.13 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $109,094 - $122,537	-657 Reduced 10.36%	5,684 $1.05 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $821,227 - $959,706	-4,847 Reduced 43.32%	6,341 $1.05 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $156,805 - $175,200	-929 Reduced 7.67%	11,188 $2.02 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $218,982 - $250,019	1,309 Added 12.11%	12,117 $2.25 Million
Q2 2017 Aug 16, 2017	BUY	N/A	10,808	10,808 $0

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Amgen Inc Transaction History